Table 4.
Vitamin K and D intake, in Crohn’s Disease, in relation to disease location and behavior.
| CD Nr of Pts |
Vit K μg/day |
SD | p Value | % RDA | Vit D μg/day |
SD | p Value | % RDA |
|---|---|---|---|---|---|---|---|---|
|
L1
33 |
124.35 | 125.34 |
pl1–l2 = n.s. pl1–l3 = n.s. pl2–l3 = n.s. |
82.95 | 7.85 | 4.63 |
pl1–l2 = n.s. pl1–l3 = n.s. pl2–l3 = n.s. |
51.49 |
|
L2
10 |
115.99 | 117.08 | 79.82 | 9.53 | 4.19 | 62.38 | ||
|
L3
46 |
97.82 | 119.14 | 67.99 | 9.34 | 4.66 | 61.10 | ||
|
inflammatory (a)
51 |
129.26 | 132.17 |
pa–b = n.s. pb–c = n.s. pa–c = n.s. |
89.29 | 9.43 | 4.78 |
pa–b = n.s. pb–c = n.s. pa–c = n.s. |
62.00 |
|
structuring (b)
26 |
97.71 | 106.35 | 64.67 | 8.74 | 4.29 | 56.53 | ||
|
perforating (c)
12 |
61.80 | 68.52 | 42.11 | 6.83 | 3.62 | 45.40 |
CD: Crohn’s Disease. Disease localization: L1 terminal ileum, L2 colon, L3 ileo-colon. n.s.: non-significant. Data expressed in μg/day and percent of RDA.